You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Autologous stem cell transplantation,

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Autologous Stem Cell Transplantation, Conditioning Trial in Xi'an (modified BEAM, BEAM)

Not yet recruiting
  • Autologous Stem Cell Transplantation
  • Conditioning
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Apr 14, 2023

Lymphoma Trial in New York (rituximab, bendamustine, melphalan)

Active, not recruiting
  • Lymphoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 10, 2023

B-cell Lymphoma Trial in Xuzhou (ASCT+CAR-T Cell Infusion)

Recruiting
  • B-cell Lymphoma
  • ASCT+CAR-T Cell Infusion
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Feb 23, 2023

Multiple Myeloma, Stem Cell Transplant Complications Trial in Boston (PARE, Waitlist Control Group)

Not yet recruiting
  • Multiple Myeloma
  • Stem Cell Transplant Complications
  • PARE
  • Waitlist Control Group
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 30, 2023

Plasma Cell Myeloma Trial in Omaha (drug, procedure, biological)

Active, not recruiting
  • Plasma Cell Myeloma
  • Omaha, Nebraska
    University of Nebraska Medical Center
Nov 21, 2022

Scleroderma, Cardiac Involvement, Autologous Stem Cell Transplantation Trial in Tuebingen (Autologous stemcell transplantation

Active, not recruiting
  • Scleroderma
  • +2 more
  • Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells
  • Tuebingen, Germany
    University Hospital Tuebingen; Department of oncology, hematolog
May 16, 2022

Multiple Myeloma, AL Amyloidosis Trial in New York (Siltuximab, The M.D. Anderson Symptom Inventory (MDASI))

Active, not recruiting
  • Multiple Myeloma
  • AL Amyloidosis
  • Siltuximab
  • The M.D. Anderson Symptom Inventory (MDASI)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 23, 2023

Multiple Myeloma Trial in Hamburg (allogeneic HSCT)

Completed
  • Multiple Myeloma
  • allogeneic HSCT
  • Hamburg, Germany
    University Medical Center Hamburg-Eppendorf
Sep 1, 2022

Diffuse Large B Cell Lymphoma Trial (Venetoclax, Carmustine, Cytarabine)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • (no location specified)
May 9, 2023

Stem Cells Mobilization, colLection and Engraftment in Newly

Recruiting
  • Multiple Myeloma
  • +3 more
  • Rome, Italy
    Fondazione Policlinico Universitario A.Gemelli IRCCS
Apr 28, 2023

Multiple Myeloma Trial in Saint Petersburg (Melphalan, Nivolumab, Autologous Stem Cell Transplantation)

Recruiting
  • Multiple Myeloma
  • Saint Petersburg, Russian Federation
    Boris V Afanasyev, MD, Prof.
Apr 4, 2022

CIBMTR Research Database

Recruiting
  • Autologous Stem Cell Transplantation
  • +6 more
    • Minneapolis, Minnesota
    • +1 more
    Jan 20, 2023

    Frontline of ASCT in High-risk DLBCL

    Recruiting
    • Diffuse Large B Cell Lymphoma
      • Beijing, Beijing, China
        Peking University People's Hospital
      Apr 26, 2023

      Diffuse Large Cell Lymphoma Relapsed/Refractory Trial in San Francisco (Ofatumumab, Etoposide, Cytarabine)

      Completed
      Has Results
      • Diffuse Large Cell Lymphoma Relapsed/Refractory
      • San Francisco, California
        University of California, San Francisco
      Jun 5, 2022

      Multiple Myeloma, Lymphoma Trial in Omaha (Resistant Starch, Maltodextrin)

      Recruiting
      • Multiple Myeloma
      • Lymphoma
      • Resistant Starch
      • Maltodextrin
      • Omaha, Nebraska
        Nebraska Medicine
      Apr 14, 2022

      Multiple Myeloma Trial in Philadelphia (CART-19 cells)

      Terminated
      Has Results
      • Multiple Myeloma
      • CART-19 cells
      • Philadelphia, Pennsylvania
        Abramson Cancer Center of the University of Pennsylvania
      Jan 4, 2023

      Diffuse Large B Cell Lymphoma Trial in Saint Louis (Blinatumomab, Autologous stem cell transplant, Carmustine)

      Active, not recruiting
      • Diffuse Large B Cell Lymphoma
      • Saint Louis, Missouri
        Washington University School of Medicine
      May 4, 2022

      Multiple Myeloma Trial in New York (CT7, MAGE-A3, and WT1 mRNA-electroporated Langerhans cells ( LCs), Standard of care)

      Completed
      • Multiple Myeloma
      • CT7, MAGE-A3, and WT1 mRNA-electroporated Langerhans cells ( LCs)
      • Standard of care
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jun 22, 2022

      Immunogenicity of COVID-19 Vaccinations in Autologous HSCT

      Not yet recruiting
      • COVID-19
      • +2 more
        • Cologne, NRW, Germany
          University Hospital of Cologne
        Oct 27, 2022

        Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)

        Active, not recruiting
        • Plasma Cell Leukemia
        • +3 more
        • Autologous Hematopoietic Stem Cell Transplantation
        • +7 more
        • Houston, Texas
          M D Anderson Cancer Center
        Oct 6, 2022

        T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)

        Terminated
        Has Results
        • T-cell Non-Hodgkin Lymphoma
        • Boston, Massachusetts
        • +1 more
        Jan 26, 2023

        Multiple Myeloma Trial in Atlanta, Chicago (procedure, drug, other)

        Recruiting
        • Multiple Myeloma
        • Autologous Hematopoietic Stem Cell Transplantation
        • +2 more
        • Atlanta, Georgia
        • +1 more
        Feb 25, 2022

        Multiple Myeloma Trial in Torino (Velcade, Melphalan, Prednisone)

        Recruiting
        • Multiple Myeloma
        • Torino, TO, Italy
          Dipartimento di Biotecnologie Molecolari e Scienze per la Salute
        May 25, 2022

        Beta-Thalassemia Trial (CS-101 injection)

        Not yet recruiting
        • Beta-Thalassemia
        • CS-101 injection
        • (no location specified)
        Sep 27, 2023

        Multiple Myeloma Trial in New York (Circadian Effective Lighting, Circadian Ineffective Lightning (CIL))

        Recruiting
        • Multiple Myeloma
        • Circadian Effective Lighting
        • Circadian Ineffective Lightning (CIL)
        • New York, New York
        • +1 more
        Feb 10, 2023